Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 13190 | 789 | 33.1 | 69% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CATHEPSIN D | Author keyword | 102 | 30% | 36% | 284 |
| 2 | PROCATHEPSIN D | Author keyword | 27 | 70% | 3% | 23 |
| 3 | UNITE HORMONES CANC | Address | 3 | 43% | 1% | 6 |
| 4 | CATHEPSIN D INHIBITORS | Author keyword | 3 | 100% | 0% | 3 |
| 5 | U148 | Address | 3 | 32% | 1% | 8 |
| 6 | LYSOSOMAL PROTEINASES | Author keyword | 3 | 45% | 1% | 5 |
| 7 | ALP56 | Author keyword | 1 | 100% | 0% | 2 |
| 8 | AUTOMATED IMMUNOPEROXIDASE | Author keyword | 1 | 50% | 0% | 2 |
| 9 | CATHEPSIN D ISOFORMS | Author keyword | 1 | 100% | 0% | 2 |
| 10 | NOTHEPSIN | Author keyword | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CATHEPSIN D | 102 | 30% | 36% | 284 | Search CATHEPSIN+D | Search CATHEPSIN+D |
| 2 | PROCATHEPSIN D | 27 | 70% | 3% | 23 | Search PROCATHEPSIN+D | Search PROCATHEPSIN+D |
| 3 | CATHEPSIN D INHIBITORS | 3 | 100% | 0% | 3 | Search CATHEPSIN+D+INHIBITORS | Search CATHEPSIN+D+INHIBITORS |
| 4 | LYSOSOMAL PROTEINASES | 3 | 45% | 1% | 5 | Search LYSOSOMAL+PROTEINASES | Search LYSOSOMAL+PROTEINASES |
| 5 | ALP56 | 1 | 100% | 0% | 2 | Search ALP56 | Search ALP56 |
| 6 | AUTOMATED IMMUNOPEROXIDASE | 1 | 50% | 0% | 2 | Search AUTOMATED+IMMUNOPEROXIDASE | Search AUTOMATED+IMMUNOPEROXIDASE |
| 7 | CATHEPSIN D ISOFORMS | 1 | 100% | 0% | 2 | Search CATHEPSIN+D+ISOFORMS | Search CATHEPSIN+D+ISOFORMS |
| 8 | NOTHEPSIN | 1 | 50% | 0% | 2 | Search NOTHEPSIN | Search NOTHEPSIN |
| 9 | PRO CATHEPSIN D | 1 | 100% | 0% | 2 | Search PRO+CATHEPSIN+D | Search PRO+CATHEPSIN+D |
| 10 | ACTIVATION PEPTIDE | 1 | 23% | 1% | 5 | Search ACTIVATION+PEPTIDE | Search ACTIVATION+PEPTIDE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | D ACTIVATION PEPTIDE | 37 | 100% | 2% | 14 |
| 2 | MCF7 CELLS | 22 | 53% | 4% | 29 |
| 3 | D EXPRESSION | 19 | 40% | 5% | 38 |
| 4 | ESTROGEN REGULATED PROTEIN | 19 | 55% | 3% | 24 |
| 5 | PROCATHEPSIN D ACTIVATION | 18 | 83% | 1% | 10 |
| 6 | D ASSAY | 17 | 100% | 1% | 8 |
| 7 | PROCATHEPSIN D | 12 | 30% | 4% | 33 |
| 8 | HUMAN PROCATHEPSIN D | 9 | 59% | 1% | 10 |
| 9 | CYTOSOLS | 8 | 33% | 2% | 19 |
| 10 | CANCER CYTOSOLS | 6 | 100% | 1% | 4 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis | 2006 | 153 | 112 | 48% |
| Cathepsin D in cancer metastasis: A protease and a ligand | 1999 | 79 | 69 | 67% |
| Cathepsin D-Many functions of one aspartic protease | 2008 | 148 | 192 | 36% |
| Biological and clinical significance of cathepsin D in breast cancer metastasis | 1996 | 90 | 57 | 63% |
| Cathepsin D: A cellular roadmap | 2008 | 68 | 43 | 56% |
| Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications | 2004 | 53 | 161 | 59% |
| Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity? | 2010 | 30 | 155 | 38% |
| The dilemma: Does tissue expression of cathepsin D reflect tumor malignancy? The question: Does the assay truly mirror cathepsin D mis-function in the tumor? | 2010 | 10 | 190 | 63% |
| Human cathepsin D | 2008 | 22 | 111 | 53% |
| CATHEPSIN-D IN THE MALIGNANT PROGRESSION OF NEOPLASTIC DISEASES (REVIEW) | 1992 | 106 | 48 | 46% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | UNITE HORMONES CANC | 3 | 43% | 0.8% | 6 |
| 2 | U148 | 3 | 32% | 1.0% | 8 |
| 3 | PATHOBIOL MOL BIOL | 1 | 40% | 0.3% | 2 |
| 4 | AUDIE L MURPHY VET ADM SERV | 1 | 50% | 0.1% | 1 |
| 5 | BIOL MOL CELLULARE ANIM | 1 | 50% | 0.1% | 1 |
| 6 | BIOQUIM CELULAR BIOFIS | 1 | 50% | 0.1% | 1 |
| 7 | ENDOCRINOL MOL CELLULAIRE CANC U540 | 1 | 50% | 0.1% | 1 |
| 8 | EXPT DIABETOL GRP | 1 | 50% | 0.1% | 1 |
| 9 | GEN SURG ENDOCRINOL | 1 | 50% | 0.1% | 1 |
| 10 | INSERM U264 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000183278 | CATHEPSIN E//ASPARTIC PROTEINASE//PEPSINOGEN C |
| 2 | 0.0000167109 | CATHEPSIN B//CATHEPSIN L//CATHEPSIN X |
| 3 | 0.0000142221 | I CELL DISEASE//MANNOSE 6 PHOSPHATE//MUCOLIPIDOSIS TYPE III |
| 4 | 0.0000125199 | CALPAIN CATHEPSIN HYPOTHESIS//OSMOTIC SENSITIVITY//LYSOSOME STABILITY |
| 5 | 0.0000116514 | UVEAL INFLAMMATION//IRIS CILIARY COMPLEX//OCULAR TISSUE |
| 6 | 0.0000088068 | TREFOIL FACTOR//TFF DOMAIN//TREFOIL PEPTIDE |
| 7 | 0.0000062931 | BREAST CARCINOMA CELL LINE//BIOTINYLATED EPIDERMAL GROWTH FACTOR//BREAST CANCER BIOPSIES |
| 8 | 0.0000056314 | FERTILITY CYCLE//CHRONOEPIDEMIOLOGY//SCREENING CAMPAIGNS |
| 9 | 0.0000047971 | AEBS//ANTIESTROGEN BINDING SITES//ANALOG II |
| 10 | 0.0000039609 | BENZHYDRYLPIPERAZINE//1 BENZHYDRYL PIPERAZINE//1 BENZHYDRYL PIPERAZINE DERIVATIVES |